Ivy Reyes Melgarejo

Ivy Melgarejo practices at Ottumwa Dialysis in Des Moines, Iowa.

Ivy Melgarejo's NPI, 1518349992, was assigned on June 23, 2015. Ivy Melgarejo holds Iowa license 48007.

Ivy Melgarejo's primary practice is Ottumwa Dialysis, at 1215 Pleasant St, Des Moines, IA 50309 in Polk County. The practice phone is (641) 682-1531.

Ivy Melgarejo's primary practice is Ottumwa Dialysis in Des Moines, Iowa. Ivy Melgarejo is also affiliated with UnityPoint Health - Iowa Methodist Medical Center. The medical group on file is Iowa Kidney Physicians. Dmand AI also links Ivy Melgarejo to 5 more hospitals, 4 dialysis centers, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ivy Melgarejo practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Ivy Melgarejo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Ivy Melgarejo is licensed in Iowa.

CMS data shows 1,847 Medicare services from Ivy Melgarejo across 13 procedure codes in 2024, for 588 Medicare patients. Medicare paid $138,384 for them.

CMS counts 588 Medicare patients who saw Ivy Melgarejo in 2024. The largest group is 65 to 74, with 213 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ivy Melgarejo's median patient age at 68, with 48% women.

In 2024, Ivy Melgarejo wrote 1,371 Medicare Part D claims for 245 patients. 92% of them were for generic drugs. CMS names the drug for 1,180 of them, across 24 drugs with 11 or more claims each, at $20,039 in total drug cost. In 2023, CMS named 942 claims across 24 drugs.

Ivy Melgarejo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ivy Melgarejo as offering telehealth.

Dmand AI links 2 papers to Ivy Melgarejo, published from 2021 to 2022. Ivy Melgarejo's most frequent co-authors are Sundaram Hariharan, MD, Chethan M. Puttarajappa, MD, MS and Rajil B. Mehta.

CMS Open Payments shows 7 general payments to Ivy Melgarejo from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Fresenius USA Marketing, Inc. paid the most, $268.